中國恆天立信國際(00641.HK)年度純利增1124.44%至7700.5萬港元 末期息1港仙
格隆匯4月1日丨中國恆天立信國際(00641.HK)公佈,截至2021年12月31日止年度,公司營業收入為26.72億港元,同比增長17.45%;公司擁有人應占年度溢利為7700.5萬港元,同比增長1124.44%;基本每股盈利為7.00港仙,董事會建議派付末期股息每股1港仙。
於2021年,新冠病毒疫情持續,令經營環境晦暗不明。全球供應鏈不穩定及原材料價格飆升更是雪上加霜,導致營運成本上升,影響集團營運表現。礙於市況疲弱,競爭更趨激烈,產品成本的上升難以向客户全部轉嫁。集團的各項核心業務,因市場不同;競爭對手有異,因而分類業績表現各有差異。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.